Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
about
Non-pharmacological measures for preventing opportunistic infection in patients with haematological malignanciesOncological emergencies associated with gastrointestinal tumorsAntiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)Prophylactic Measures During Induction for Acute Myeloid Leukemia.Infections in Cancer Patients with Solid Tumors: A Review.Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaGrowth factor use in medication-induced hematologic toxicity.Clinical predictive models for chemotherapy-induced febrile neutropenia in breast cancer patients: a validation study.Independent factors for prediction of poor outcomes in patients with febrile neutropeniaClinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropeniaFebrile neutropenia in hematologic malignancies.Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapyFluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institution.Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factorsTime to antibiotics and outcomes in cancer patients with febrile neutropeniaPharmacodynamics of cytarabine induced leucopenia: a retrospective cohort studyHow to treat severe infections in critically ill neutropenic patients?Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancerAssessment of adverse events via a telephone consultation service for cancer patients receiving ambulatory chemotherapyEpidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey.Utility of the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index Score as a Criterion for Nonadmission in Febrile Neutropenic Patients with Solid TumorsAmerican Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort studyDaptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia.How I diagnose and treat neutropenia.Bloodstream infections in neutropenic cancer patients: A practical update.Use of ED and hospital services for patients with acute leukemia after induction therapy: one year follow-upA nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropeniaCausative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line-Associated Bloodstream Infections From Oncology Settings, 2009-2012.Communicating safe outpatient management of fever and neutropenia.Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.The Emergency Care of Patients With Cancer: Setting the Research Agenda.Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer.Hindlimb suspension and SPE-like radiation impairs clearance of bacterial infections.
P2860
Q24193921-44C6AE38-7834-4BFB-8E95-0E9B52C8F9E6Q26783725-84749088-84FF-4A1B-BA87-8FBCFD3933A1Q26801716-AEB523EB-EE58-48CF-970C-EE7F84E86028Q30235496-60DF40FD-3AAE-4D81-82E1-1803AE7011ACQ30238576-39EBFCEA-3129-48CC-B253-64128EF3B48BQ33413142-CC3FC355-C675-4FD2-9417-212E67CC4D0BQ33417812-3A2F333B-B607-423F-ADD6-82D6283CE4A7Q33778817-29B6B140-C6D0-45C6-A6F7-6A512DB50EF9Q34350273-6D4C87D5-DA7D-49AE-A263-4A6F5CF1FABBQ34362184-59F77621-A9A1-4C69-8F84-39230025EA47Q34403621-CEE100A5-B6F4-401A-B880-6EEA1681AF9FQ34655730-8665735A-B0F3-482E-9E4A-E35C3117E3A8Q34667166-85001342-3DFD-471D-BEED-D9EC43045619Q34670717-AFB96400-0EFF-41F6-B2F4-8B952DE88971Q34941030-F52FA5A7-4334-4905-98D4-C07D6C1CAE4AQ35078855-055C4037-8B8B-4EA4-B4B3-06AA1520C90DQ35091386-4539316B-676F-4969-9E27-367FBBB41B66Q35123683-2951DF77-1991-4DF8-B48F-CA3B6B6E341BQ35143387-03DF3EBE-52EA-4262-AD64-3A8659A71184Q35286194-8C2C0254-3C57-448F-BD8A-0661FAF31561Q35457899-8EABB9CD-BC0D-4B25-B29F-6898CFE18F7BQ35469953-4F1DD2AB-FB36-4F3C-B932-5594FB3D71B7Q35713642-7E44D07B-C1EF-46EE-9D8B-E621DCD3E9EEQ35753638-D519A49E-1238-4D61-8EAA-D437AECCB0E3Q35799944-B3AB624E-3A09-4623-988D-492D12ADC1BEQ35846480-53AEFA30-964D-49B9-A79D-BF08C260FF5BQ35894574-C99B6216-6411-4462-AB10-41C9E497B691Q35916166-266A0CEC-1DA9-453A-9BC2-452FFEF3131DQ36059234-CAAC5DEB-2414-416B-AAC4-7955B1D7F106Q36093849-A8B36312-C806-47DB-83B1-9800747427AAQ36342838-C07A8B7A-978B-482D-B167-9930320F7DADQ36913345-BE50FA75-C26F-4783-8026-D520180222B1Q36934000-58837C2E-CC5E-4D9B-B43C-DDD2A9C8300BQ36964331-D0960E11-9471-4EE2-8F2D-E5B521FC6E21Q36973200-88EFC67F-A838-4CFD-AF09-29DA61FBB2CAQ37008525-ECA77BB2-1DDE-4AF9-BA0D-057481A13F36Q37152897-EC143146-5E4B-4486-9627-D054F841BED3Q37211558-4B8354BF-4A0F-496A-B3DC-E710289ADB6BQ37287576-D4B2B230-4415-453F-9470-03DE2E9EC371Q37484256-2EA53990-D48C-4C9D-AE49-761120392F8D
P2860
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@ast
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@en
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@nl
type
label
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@ast
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@en
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@nl
prefLabel
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@ast
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@en
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@nl
P2093
P356
P1476
Antimicrobial prophylaxis and ...... y clinical practice guideline.
@en
P2093
Amelia A Langston
Charise Gleason
Christopher R Flowers
Clare Karten
Douglas K Hawley
Eric J Bow
Jerome Seidenfeld
Kenneth V I Rolston
Kieren A Marr
Nicole M Kuderer
P304
P356
10.1200/JCO.2012.45.8661
P407
P577
2013-01-14T00:00:00Z